Notably, rearrangements of RUNX1‐RUNX1T1 (OR = 5.025, [1.762‐14.329], P = .003) or CBFB‐MYH11 (OR = 20.285, [4.121‐99.848], P < .001), which were commonly referred to as core binding factor AML (CBF‐AML), were independently associated with the occurrence of PTR in multivariate analysis (Table 3). Here, MYH11 is linked to acute myeloid leukemia.